Contrast-enhanced Spectral Mammography (CESM) is an emerging and promising functional imaging modality that tries to address the paucity of physiologic-based tumor imaging for the detection of breast cancer.
INTRODUCTION
Mammography is the only breast imaging modality with a demonstrated ability to reduce mortality. 1 A review by Myers et al., confirmed the findings of several published studies that screening mammography in women aged 40-79 reduces breast cancer mortality rates by 20%-50%, with extent of benefit varying by age, as well as study design (RCT vs. observational). 2 However, mammography has a population-based sensitivity of only approximately 80% 1 which is further corroborated by the findings of Carney et al., that showed that with increasing breast density, the sensitivity of mammography decreases to 62% in women with dense breasts. 3 Breast density refers to the proportion of glandular and fibrous breast tissue to the amount of fatty tissues in a woman's breast. It has been shown that women who have high density breasts are 4-5x more likely to get breast cancer than women with low breast density. 4, 5 It is also statistically significantly greater among Asian women than among African American and white women. 
Contrast-Enhanced Spectral Mammography (CESM)
Contrast-enhanced Spectral Mammography (CESM) is a novel imaging modality that demonstrates the physiologic uptake of contrast by breast cancer. The depiction of breast cancers using contrast media is based on the biologic principle of the rapid formation of tumoral microvessels that render malignancyassociated vessels more permeable to contrast agent than normal tissue, resulting in tumor enhancement. 7 It has been proposed by Chang et al. , that the use of a standard iodinated CT contrast agent and x-ray imaging might also give functional information with a preferential uptake in breast cancers. 8 An early study done among 26 subjects in 2003 by Lewin et al., of the University of Colorado utilizing dual-energy contrastenhanced mammography showed tumor enhancement in 13 of the subjects that had subsequent biopsy-proven invasive cancers. Furthermore, a recent study by Patel et al., showed that CESM had a reduced exam time of 7-10 minutes compared to MRI with 30-60 minutes as well as reduced staff time of 25 minutes compared to 60 minutes. 13 The disadvantages include its contraindication for use in patients with abnormal renal function or if they have a known reaction to iodine contrast. Furthermore, it is not advised for pregnant or lactating women or those who are diagnosed with hyperthyroidism.
How is it performed?
Before a CESM exam is initiated, a thorough history is elicited from the patient with emphasis on allergy history and previous or known allergy to iodine contrast media. The creatinine level is obtained at least a week before the scheduled exam. Ideally, for premenopausal women, the timing of the exam should coincide with Days 7-14 of her menses, to reduce background parenchymal enhancement.
An IV is inserted into the forearm or antecubital vein and a power injector at a rate of 3 ml/s infuses iodinated contrast agent. The volume is typically calculated at 1.5-ml/kg bodyweight. The iodine concentration ranges from 300 mg/ml to 370 mg/ml.
After infusion of the contrast media, let 2 minutes pass before positioning the patient for the standard mammographic views (Mediolateral Oblique and Craniocaudal views) of each breast. For each projection, two energy pairs -low energy and high energy are generated in a single compression. Severe acute reactions to contrast media occur in 4/10,000 (0.04%) patients. 14 According to a study of Lalji et al., the low-energy CESM images are non-inferior to Full-Field Digital Mammography (FFDM) images with no significant differences in image quality, average glandular dose, and contrast detail. 15 The LE images therefore are equivalent to a standard mammogram. The additional radiation dose from the HE images in CESM was approximately 20% that of routine Full-Field Digital Mammography or the equivalent of 1 additional view.
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DISCUSSION
The core principle in functional imaging is based on tumor enhancement secondary to tumor neoangiogenesis. The process of tumor neoangiogenesis plays a central role in the growth and spread of tumors. 16 Tumor cells secrete vascular endothelial growth factor (VEGF), a potent angiogenesis activator that stimulates the formation and proliferation of endothelial cells. 17 The newly grown vessels are immature and differ from normal capillaries. They are tortuous and irregular, resulting in poorly efficient perfusion, they are leaky (especially to macromolecules), and they are independent of the normal mechanisms of regulation of the capillary blood flow. Hemodynamic characteristics of immature neovessels can be conservatively assessed by dynamic contrast-enhanced magnetic resonance imaging or computed tomography. Tissue enhancement depends on arterial input function, kinetics of distribution of blood into the capillary bed, leakage across the capillary walls, and volume of the interstitial space. 16 In our current setting, the detection of breast cancer mainly utilizes analog film mammography, conventional digital mammography, digital breast Tomosynthesis (DBT/2D+3D Mammography) and breast ultrasound, which are based on morphologic (anatomic) information, as opposed to MRI (Magnetic Resonance Imaging) which gives functional information. MRI, however, is limited in its use in our local setting because of its limited availability and the cost is prohibitive.
The sensitivity of CESM was found to be high (98%), underscoring its potential to rival the diagnostic performance of MRI, but with added advantages of improved accessibility and lower cost. 18 In women with dense breasts, Cheung et al., demonstrated that CESM is superior to mammography in both sensitivity and specificity with improvement from 71.5% to 92.7% and 51.8% to 67.9%, respectively.
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Akin to the improvements and technological advances made in the field of Pathology, namely, with the development of novel molecular characterization of breast cancer with cellular markers, functional-based imaging of breast cancer is poised to change the paradigm of current diagnostic practice. Dual-energy Contrast-enhanced Spectral Mammography may provide added value in determining the microcalcifications that show enhancement with a diagnosis favorable to cancer or a lack thereof as virtually diagnostic for non-malignant or noninvasive subgroup of cancers. 20 Likewise, its ability to identify multifocal or multicentric disease enables it to adequately and simultaneously stage both breasts 21 for better pre-biopsy planning.
Local Experience
The first institute to acquire Contrast-enhanced Spectral Mammography is Health Cube Advanced Medical Imaging Unit in March 2016. It was initially utilized as part of the surveillance monitoring of patients with either mastectomy or post-breast conservation surgery and is currently integrated into the diagnostic workflow in the work-up of patients with clinically suspicious findings, particularly those who have dense breasts. Contrast-enhanced spectral mammography stands to be a viable and practical diagnostic imaging modality that can contribute to increased cancer detection rate and improve breast cancer care in our country.
ACKNOWLEDGMENTS
The authors thank the following esteemed colleagues: Sherry L. The two cases included in this case series showcase the ability of CESM to image cancer whether in dense or non-dense breasts. The first case illustrates cancer without background parenchymal enhancement in a non-dense breast while the second case shows two (2) foci of cancer in a patient with dense breasts with additional background parenchymal enhancement.
CONCLUSION
The trend towards molecular and functional-based diagnosis of breast pathology will continue and potentially become the standard of care in the near future, making it possible for a tailored and targeted approach in the improved management of breast cancer. 
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